Preparation, Characterization, and In Vitro/In Vivo Evaluation of 3-O-β-D-Galactosylated Resveratrol-Loaded Polydopamine Nanoparticles
- 17 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 22 (7), 1-7
- https://doi.org/10.1208/s12249-021-02079-7
Abstract
3-O-β-D-galactosylated resveratrol (Gal-Res) was synthesized from resveratrol (Res) and 3-O-β-D-galactose (Gal) in our previous study. In order to improve the pH sensitivity and bioavailability of Gal-Res, Gal-Res nanoparticles (Gal-Res NPs) were prepared using polydopamine (PDA) as a drug carrier. The drug loading (DL %) and entrapment efficiency (EE %) of Gal-Res NPs were 46.80% and 88.06%. The average particle size, polydispersity index (PDI), and Zeta potential of Gal-Res NPs were 179.38 ± 2.83 nm, 0.129 ± 0.013, and − 28.05 ± 0.36 mV, respectively. The transmission electron microscope (TEM) showed that Gal-Res NPs had uniform spherical morphology. Compared with the fast release of raw Gal-Res, the in vitro release of Gal-Res NPs was slow and pH-sensitive. The results of the blood vessel irritation and hemolysis test demonstrated that Gal-Res NPs had good hemocompatibility. The pharmacokinetics study in rats showed that area under the curve of plasma drug concentration time (AUC0→600) and half-life (t1/2) of Gal-Res NPs were enhanced 1.82-fold and 2.19-fold higher than those of raw Gal-Res. The in vivo biodistribution results showed that Gal-Res NPs were more distributed in liver tissue than Gal-Res. Gal-Res NPs with high bioavailability and liver accumulation were hopeful drug delivery systems (DDS) to treat liver diseases. Graphical abstractKeywords
This publication has 39 references indexed in Scilit:
- A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's diseaseColloids and Surfaces B: Biointerfaces, 2015
- Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicinColloids and Surfaces B: Biointerfaces, 2015
- Interferences of resveratrol with fura-2-derived fluorescence in intracellular free-Ca2+ concentration determinationsCytotechnology, 2015
- Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applicationsJournal of Controlled Release, 2015
- Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseasesFood and Chemical Toxicology, 2013
- Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability studyInternational Journal of Nanomedicine, 2012
- Protein adsorption on dopamine–melanin films: Role of electrostatic interactions inferred from ζ-potential measurements versus chemisorptionJournal of Colloid and Interface Science, 2010
- Dose-Dependency of Resveratrol in Providing Health BenefitsDose-Response, 2010
- Resveratrol as an anticancer nutrient: molecular basis, open questions and promisesThe Journal of Nutritional Biochemistry, 2005
- Beneficial effect of nimodipine on metabolic and functional disturbances in rabbit hippocampus following complete cerebral ischemia.Stroke, 1989